|
|
||||||||
J Thorac Cardiovasc Surg 2002;123:573-575
© 2002 The American Association for Thoracic Surgery
Brief Communications |
From the Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Received for publication Sept 25, 2001; accepted for publication Oct 23, 2001. Address for reprints: R. S. Bonser, FRCP, FRCS, Cardiothoracic Surgical Unit, Queen Elizabeth Hospital, University Hospital NHS Trust, Edgbaston, Birmingham B15 2TH, United Kingdom (E-mail: r.s.bonser{at}bham.ac.uk).
Aortic root dilatation is the commonest cause of severe aortic regurgitation and its incidence increases with age.
1 The need for surgery is determined both by the severity of aortic regurgitation and by the extent of aortic dilatation. Aortic valve replacement is offered to those patients with symptomatic severe aortic regurgitation with or without compromise of left ventricular dynamics. However, in the context of the dilated aorta, isolated aortic valve replacement is associated with a late incidence of aortic rupture.
2 Even if an aortoplasty procedure is performed at the time of valve replacement, aneurysm recurrence rates are high. Therefore, dilatation of the aortic root to greater than 40 mm in association with aortic regurgitation is usually considered an indication for root replacement.
3
The older patient with this condition provides a therapeutic challenge. Good results for aortic prosthetic replacement or valve-sparing repair in younger patients have been demonstrated.
4 However, the friable nature of the tissues in elderly patients makes these surgical options less attractive in this group.
Recent work has shown the excellent long-term results that can be achieved with homograft replacement of the aortic valve in elderly patients with isolated valve disease.
5 It would appear that the rate of freedom from tissue failure increases with increased age, which in addition to the excellent hemostatic and handling properties of these grafts makes them particularly suitable for use in the mature patient. In addition, the desire to avoid anticoagulation in the elderly patient increases the need for a biologic valve substitute.
Extrapolation of these data led us to consider the use of a combination homograft prosthetic replacement strategy in patients with aortic regurgitation and aneurysm of the proximal aorta.
Patients and methods
Between January 1995 and March 2001, 29 patients (7 male, mean age 74 years; range 58-85 years) underwent composite replacement of the aortic root (homograft) and ascending aorta/arch (polyester graft [Gelweave; Sulzer Vascutek Ltd, Renfrewshire, Scotland]). Aortic arch replacement was performed in 22 patients and open distal anastomosis in 7 patients.
After induction of anesthesia and insertion of a monitoring line, median sternotomy was performed. Cardiopulmonary bypass was initiated with right atrial drainage and either arch or femoral arterial return. After a period of hypothermic circulatory arrest, the arterial return was transferred to the reconstructed aorta via the side arm of the prosthetic graft (Sulzer Vascutek Gelweave Ante-Flo).
After median sternotomy, the pericardium was opened and purse-string sutures were placed in the right atrium and ascending aorta or femoral artery. Cannulation was performed and cardiopulmonary bypass was commenced. The patients were routinely cooled to 15°C with alpha-stat pH control. Once bypass was established, the aorta was mobilized. If arch repair was to be performed, the recurrent laryngeal nerve was identified and protected and the ligamentum arteriosum divided. The ascending aorta was crossclamped, the heart electrically fibrillated, the aorta opened, and cold blood cardioplegic solution was instilled directly into the coronary ostia. The aortic valve was excised and the native coronary ostia were mobilized on buttons of the aortic wall. Homograft root replacement was undertaken with simple interrupted 4-0 polypropylene sutures to the anulus. The coronary buttons were reimplanted with 5-0 continuous polypropylene. Suture-line integrity was assessed under direct vision during delivery of a further dose of cardioplegic solution. Attention was next directed to the remaining aorta. At 15°C, the circulation was arrested, the crossclamp removed, and the aneurysmal aorta excised. If the aneurysm extended into the aortic arch, then a Carrel patch was fashioned from the epiaortic vessels. The distal anastomosis was performed under direct vision. If arch replacement was undertaken, a section of graft material was excised opposite the Carrel patch, anastomosis was performed, and the arterial return was transferred to the perfusion limb of the graft (Gelweave Ante-Flo, Sulzer Vascutek) after rigorous arch air drill. The graft-homograft anastomosis was then fashioned. All graft anastomoses were formed with buttressed continuous 4-0 polypropylene suture. Hemostasis was checked and fibrin glue applied to the proximal anastomoses. After air drill, rewarming, and weaning from bypass, hemostasis was secured and the chest closed. Operative technique is further detailed inFigure 1.
|
Cardiopulmonary bypass and hypothermic circulatory arrest times were a mean of 188 ± 38 and 35 ± 13 minutes, respectively, with a cardiac ischemic period of 139 ± 19 minutes. There were 3 inhospital deaths, 2 from low cardiac output syndrome and 1 from pneumonia (overall survival to discharge 89%). The median intensive treatment unit and cardiac hospital stays in survivors were 2 days (range 1-33 days) and 12 days (range 5-47 days), respectively. Two patients required temporary tracheostomy. Follow-up is 100%, and at a mean of 20 months there have been 3 late deaths at 13, 37, and 47 months (rupture of a descending aortic aneurysm, bronchopneumonia, and bronchopneumonia, respectively). Median survival was 45.5 months and Kaplan-Meier data are shown inFigure 2. All survivors remain in New York Heart Association class I or II, requiring only aspirin and antihypertensive medication. Serial prospective echocardiograms show no patient with greater than trivial aortic regurgitation, and all computed tomographic scanning surveillance is satisfactory. There have been no episodes of thromboembolism.
|
The use of a composite homograft root with a prosthetic extension in elderly patients with aortic aneurysm and proximal aortic disease has several potential advantages, including (1) use of a valve prosthesis that has improving results with advanced age, (2) the ability to deal fully with the arch disease, and (3) the avoidance of anticoagulation. This novel technique can be used to achieve good results in this group of elderly patients. Although early mortality was higher than in published series of homograft replacement alone,
5 the more extensive nature of this operation and the more elderly population still allow us to conclude that this is a valuable operative strategy in this group.
There have been no midterm valve failures. This finding is in keeping with that of Lund and associates,
5 who demonstrated an improved allograft survival in the elderly patient. All patients in this series have excellent neoaortic valve function on transthoracic echocardiography. We believe that this composite approach may be an optimal strategy for aneurysm of the proximal aorta with aortic regurgitation in elderly patients.
Acknowledgments
We are indebted to the anesthetic, technical, and nursing staffs of the cardiothoracic surgical unit, who have supported this program.
References
This article has been cited by other articles:
![]() |
A. John, B. Al-Hariri, J. Ackemann, M. El-Mehsen, S. Roethemeyer, and H. Warnecke Subcoronary Implantation of a Stentless Valve in Patients with Aortic Aneurysms Asian Cardiovasc Thorac Ann, October 1, 2008; 16(5): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. John, B. Al-Hariri, J. Ackemann, and H. Warnecke Replacing the diseased aortic valve and the proximal aorta in the elderly patient Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 939 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kalkat and R. S. Bonser Obstructive pneumonia: an indication for surgery in mega aorta syndrome Ann. Thorac. Surg., April 1, 2003; 75(4): 1313 - 1315. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |